EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Interpretable Machine Learning Approach for Predicting Depressive and Anxiety Symptoms After Treatment in Patients with Drug-Resistant Epilepsy

Zhengyanran Xu, Xinyuan Zhao, Helin Wang, Yang Chen, Yi Guo, Lijun Yao

Brain Sciences · 20.11.2026 · 16 (11) · 1276

DOI: 10.3390/brainsci16111276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 20.11.2026. Verfasst von Zhengyanran Xu und 5 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psychiatric comorbidities, particularly anxiety and depression, significantly impair quality of life and psychosocial functioning in patients with drug-resistant epilepsy (DRE). This study aimed to develop and evaluate interpretable machine learning (ML) models to predict post-treatment depressive and anxiety symptoms using exclusively pre-treatment baseline data.

Methods

Baseline demographic, clinical, and psychological data from a cohort of DRE patients were analyzed. Eight ML algorithms were trained and evaluated using repeated nested cross-validation to predict post-treatment depressive and anxiety symptoms as separate outcomes. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), Brier score, precision, recall, and F1-score. SHAP (SHapley Additive Explanations) analysis was performed for the Random Forest models to identify the key predictors for each outcome.

Results

Five of the eight trained models achieved a mean AUC ≥ 0.80 for depressive symptoms, and seven for anxiety symptoms. Random Forest achieved the highest mean AUC for both depressive symptoms (0.838 ± 0.008) and anxiety symptoms (0.862 ± 0.011). SHAP analysis identified that baseline mood severity, treatment modality, and seizure-related variables as the primary predictors across both models.

Conclusions

The findings indicate that post-treatment depressive and anxiety symptoms in DRE patients can be predicted before treatment using routine baseline data, highlighting the potential of baseline clinical information for early risk stratification in this high-risk population.

Förderung

  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Xu, Z., Zhao, X., Wang, H., Chen, Y., Guo, Y., & Yao, L. (2026). An Interpretable Machine Learning Approach for Predicting Depressive and Anxiety Symptoms After Treatment in Patients with Drug-Resistant Epilepsy. Brain Sciences, 16(11), 1276. https://doi.org/10.3390/brainsci16111276

Vancouver

Xu Z, Zhao X, Wang H, Chen Y, Guo Y, Yao L. An Interpretable Machine Learning Approach for Predicting Depressive and Anxiety Symptoms After Treatment in Patients with Drug-Resistant Epilepsy. Brain Sciences. 2026;16(11):1276. doi:10.3390/brainsci16111276

BibTeX
@article{Xu2026,
  author = {Xu, Zhengyanran and Zhao, Xinyuan and Wang, Helin and Chen, Yang and Guo, Yi and Yao, Lijun},
  title = {An Interpretable Machine Learning Approach for Predicting Depressive and Anxiety Symptoms After Treatment in Patients with Drug-Resistant Epilepsy},
  journal = {Brain Sciences},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1276},
  doi = {10.3390/brainsci16111276}
}
Kostenlos starten →